Life Sciences / Induced Pluripotent Stem Cells- Global Growth,Trends And Forecast By Types,By Application,By Regions And By Key Players-Thermo Fisher Scientific Inc
Induced Pluripotent Stem Cells- Global Growth,Trends and Forecast By Types,By Application,By Regions and By Key Players-Thermo Fisher Scientific Inc
Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the Global Induced Pluripotent Stem Cells size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 8.7% during the review period (2022 to 2027).
Global Induced Pluripotent Stem Cells Overview
The global induced pluripotent stem cells (iPSCs) market is expected to gain market growing in the forecast period of 2022 to 2027. Data Bond that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2027 and is expected to reach USD 2,081.08 million by 2027. Increasing research activities over stem cell treatments act as driver for the induced pluripotent stem cells (iPSCs) market growth.
The induced pluripotent stem cells are type of cells derived from the adult somatic tissues and reprogrammed with set of genetic factor and factors to gain pluripotent nature. Certain genes and factors are added to attain sure properties of embryonic stem cells. The induced pluripotent cells being nearly identical to cell donor they aid in disease demonstrating. Retroviruses are commonly used as vectors to reprogram persuaded pluripotent stem cells. Main requests of persuaded pluripotent stem cells are in disease modelling, drug detection and development, toxicity studies and gene therapies. They are extensively used in treatments for cardiovascular diseases, diabetes mellitus and various kinds of cancer. Humanoid induced pluripotent stem cells shows the relevant properties of disease as it carries the specific genotype of the disease, thereby enables novel therapeutic options in patient specific way.
Who are the Prime Players in Global Induced Pluripotent Stem Cells?
The Global Induced Pluripotent Stem Cells includes identification and analysis of the various market participants competing in the global market. Prime competitors include Thermo Fisher Scientific Inc., FUJIFILM Corporation, LumaCyte, Horizon Discovery Ltd., Hopstem Biotechnology LLC., Takara Bio Inc., Cell Applications, Inc., Citius Pharmaceuticals, Inc., Lonza., Evotec SE., Fate Therapeutics, Universal Cells Inc. (An Astellas Company), Axol Bioscience Ltd., R & D Systems, Inc., Charles River Laboratories International, Inc., Corning Incorporated, REPROCELL Inc., Applied StemCell., Merck KGaA, GeneCopoeia,
Industry News and Updates:
April 19, 2022: Takara Bio Announces a Novel Brain-Tropic AAV Vector "CereAAV™" for Gene Therapy
Takara Bio Inc., an innovative biotechnology company, announced they have developed a new brain-tropic adeno-associated virus (AAV) vector, CereAAVTM, for gene therapy. CereAAVTM, generated by the combination of the genetic engineering modification of AAV2 and Takara Bio’s unique technique, is successfully shown to be highly brain-tropic. Takara Bio will continue further development to apply this novel technology for clinical use.
What are the major Applications, Types and Regions for Global Induced Pluripotent Stem Cells?
Market is segmented based on the type, applications, companies and regions.
By Types, it is segmented into
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
By Application, it is segmented into
Drug development and Discovery
Regenerative Medicine
Toxicology Studies
Others
Global Induced Pluripotent Stem Cells Regional Analysis
North America dominated the market with a revenue share of more than 52% in 2020 The robust business model in the U.S. and Canada contributed to the market growth in the region. Moreover, organizations are investing in research programs related to iPSCs. Europe is expected to witness steady growth over the forecast period. The development of the iSC accelerates the research activities about iPSCs in this region
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Global Induced Pluripotent Stem Cells describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Induced Pluripotent Stem Cells report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Global Induced Pluripotent Stem Cells scope?
Report Attributes
Report Details
Forecast Period 2022 to 2028 CAGR
CAGR of 8.7% during the review period (2022 to 2027).
Yes, the report can be customized as per your needs
Growth Drive –
In terms derived cell, cardiomyocytes segment accounted for the largest share in the global market and is anticipated to grow further with the same trend during the forecast retro. Cardiomyocytes bring major advantages to investigators owed to their nonstop and reliable supply that can be practical in diverse applications.
Based on application, the drug development & discovery emerged as the major segment and led the major growth for the market. iPSCs find wide application in safety and effectiveness valuation throughout the drug growth process.
Implant Therapeutics, a US startup, has signed a research contract with the Belgian biotech to gain access to induced pluripotent stem cells (iPSC), including differentiation techniques, hypoimmunogenic cell lines, and expertise.
Frequently Asked Question
What is the study period of this market?
The Global Induced Pluripotent Stem Cells is studied from 2022-2027.
Who are the prime players in the Global Induced Pluripotent Stem Cells?
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
